What is it about?
Our findings demonstrate that in atrial fbrillation patients treated with vitamin K antagonists, impaired fibrinolysis predisposes to thromboembolism, but not to bleeding.
Photo by National Cancer Institute on Unsplash
Why is it important?
Our study suggests that clot lysis time (CLT) may provide additional prognostic information for anticoagulated patients with AF
Read the Original
This page is a summary of: Clot Lysis Time Predicts Stroke During Anticoagulant Therapy in Patients with Atrial Fibrillation, Canadian Journal of Cardiology, August 2019, Elsevier, DOI: 10.1016/j.cjca.2019.08.001.
You can read the full text:
The following have contributed to this page